Last reviewed · How we verify
Oncology
Approved treatments
- Fludeoxyglucose F-18 · Downstate Clincl
Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions. - Fludeoxyglucose F-18 · 3D Imaging Drug
Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Oncology patent landscape — cliff calendar, originator estates, attackable patents
- Oncology treatment landscape brief
- Oncology treatment updates RSS
Frequently asked questions about Oncology
What drugs treat Oncology?
Tracked treatments include Fludeoxyglucose F-18.
What is the treatment for Oncology?
Standard treatment for Oncology includes Fludeoxyglucose F-18. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Oncology patent cliff · Oncology CI report
- Treatment: Fludeoxyglucose F-18 · Downstate Clincl
- Treatment: Fludeoxyglucose F-18 · 3D Imaging Drug
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing